Production (Stage)
Neural Therapeutics Inc.
NURL
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 181.90K | 377.50K | 47.20K | 48.40K | 17.10K |
| Total Receivables | 28.50K | 7.50K | 21.50K | 20.00K | 15.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.80K | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.10K | 1.10K | 1.10K | -- |
| Total Current Assets | 228.20K | 386.00K | 69.90K | 69.50K | 32.70K |
|
|
|||||
| Total Current Assets | 228.20K | 386.00K | 69.90K | 69.50K | 32.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 228.20K | 386.00K | 69.90K | 69.50K | 32.70K |
|
|
|||||
| Total Accounts Payable | 26.80K | 46.20K | 75.50K | 44.00K | 35.80K |
| Total Accrued Expenses | 97.00K | 146.40K | 203.70K | 169.60K | 79.70K |
| Short-term Debt | -- | 8.20K | 8.30K | 8.10K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 123.80K | 200.90K | 287.50K | 221.70K | 115.50K |
|
|
|||||
| Total Current Liabilities | 123.80K | 200.90K | 287.50K | 221.70K | 115.50K |
| Long-Term Debt | 533.10K | 488.30K | 268.10K | 270.40K | 271.70K |
| Short-term Debt | -- | 8.20K | 8.30K | 8.10K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 71.80K | 72.40K | 36.40K |
| Total Liabilities | 656.90K | 689.10K | 627.30K | 564.50K | 423.60K |
|
|
|||||
| Common Stock & APIC | 2.55M | 2.04M | 2.09M | 2.11M | 2.12M |
| Retained Earnings | -3.86M | -3.01M | -3.04M | -2.99M | -2.86M |
| Treasury Stock & Other | 885.70K | 662.20K | 392.60K | 390.60K | 347.10K |
| Total Common Equity | -428.70K | -303.10K | -557.50K | -495.00K | -390.80K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -428.70K | -303.10K | -557.50K | -495.00K | -390.80K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -428.70K | -303.10K | -557.50K | -495.00K | -390.80K |
|
|
|||||